Joseph R. Schneider, MD, PhD, Martha D. McDaniel, MD, Daniel B

Slides:

Advertisements

Similar presentations

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Advertisements

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease Ramon Berguer, MD, PhD, Mark D. Morasch,

Is long vein bypass from groin to ankle a durable procedure

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D.

Pedal bypass versus tibial bypass with autogenous vein: A comparison of outcome and hemodynamic results Joseph R. Schneider, MD, PhD, Daniel B. Walsh,

Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease? Marc A. Passman,

Richard R. Proia, MD, Daniel B. Walsh, MD, Peter R. Nelson, MD, John P

A new valvulotome for in situ bypass grafts

Enrique Criado, MD, Steven J. Burnham, MD, Ellis A

Axillofemoral bypass: A tool with a limited role

Malcolm O. Perry, MD, Richard Kempczinski, MD

Durability of the in situ saphenous vein arterial bypass: A comparison of primary and secondary patency Dennis F. Bandyk, M.D., Hermann W. Kaebnick,

Healing rates and cost efficacy of outpatient compression treatment for leg ulcers associated with venous insufficiency William A. Marston, MD, Robert.

Andrea Mingoli, MD, Paolo Sapienza, MD, Richard J

Mesenteric stenting for chronic mesenteric ischemia

Return to well-being and function after infrainguinal revascularization Gary W. Gibbons, MD, Anne M. Burgess, RN, Edward Guadagnoli, PhD, Frank B. Pomposelli,

Cost-effectiveness of carotid endarterectomy in asymptomatic patients

Vein graft lesions: Time of onset and rate of progression

Axillopopliteal bypass for limb salvage

Robert B. Rutherford, MD, J. Dennis Baker, MD, Calvin Ernst, MD, K

Infrainguinal revascularizations in octogenarians and septuagenarians

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Peripheral atherectomy with the rotablator: A multicenter report

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

Mark F. Fillinger, MD, Richard J. Baker, MD, Robert M

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

Michael A. Curi, MD, MPA, Peter J. Pappas, MD, Michael B

Carotid endarterectomy in octogenarians: Comparison with patient characteristics and outcomes in younger patients Joseph R. Schneider, MD, PhD, Julie.

Joseph R. Schneider, MD, PhD, Julie S. Droste, BSN, RN, John F

Infrainguinal arterial reconstruction for claudication: Is it worth the risk? An analysis of 409 procedures John Byrne, MD, R.Clement Darling III, MD,

Long-term outcome after early infrainguinal graft failure

Stent placement for treatment of central and peripheral venous obstruction: A long-term multi-institutional experience Gustavo S.C. Oderich, MD, Gerald.

Ryan M. Svoboda, Kristina A. Giles, Samantha A. Connell, Daniel B

Lewis B. Schwartz, MD, Michael Belkin, MD, Magruder C

Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations Dirk Th. Ubbink, MD,

Ramon Berguer, MD, PhD, Lisa M. Flynn, MD, Ronald A

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Javier G. Jimenez, MD, Thomas S. Huber, MD, PhD, C

Current use of inferior vena cava filters

Long-term assessment of cryopreserved vein bypass grafting success

Anthony D. Whittemore, MD, Magruder C. Donaldson, MD, John A

Composite sequential bypasses to the ankle and beyond for limb salvage

Spencer W. Galt, MD, Fritz R. Bech, MD, Martha D

Joseph G. Magnant, MD, Jack L. Cronenwett, MD, Daniel B

Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H

The durability of endovascular treatment of multisegment iliac occlusive disease Richard J. Powell, MDa, Mark Fillinger, MDa, Michael Bettmann, MDb, Robert.

Peripheral vascular bypass in juvenile-onset diabetes mellitus: Are aggressive revascularization attempts justified? Christopher J. Kwolek, MD, Frank.

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: Six-year results of a randomized clinical trial Gijs J. Aalders,

Angioscopy-guided semiclosed technique for in situ bypass with a novel flushing valvulotome: Early results Peter Stierli, MD, Peter Aeberhard, MD Journal.

Surgical management of severe acute lower extremity ischemia

Early results of stent-grafting to treat diffuse aortoiliac occlusive disease Eva M Rzucidlo, MD, Richard J Powell, MD, Robert M Zwolak, MD, PhD, Mark.

Carotid biaxillary bypass: A new operation

Peter G. Kalman, M. D. , Marilyn Hosang, R. N. , Claudio Cina, M. D

Should patient age be a consideration in carotid endarterectomy?

Exposure of femoral vessels by a suprainguinal incision

Secondary aortoenteric fistula: Contemporary outcome with use of extraanatomic bypass and infected graft excision Laurie M. Kuestner, MD, Linda M. Reilly,

Intragraft drug infusion as an adjunct to balloon catheter thrombectomy for salvage of thrombosed infragenicular vein grafts: A preliminary report Daniel.

Long-term results of arterial allograft below-knee bypass grafts for limb salvage: A retrospective multicenter study J.N. Albertini, MD, X. Barral, MD,

Determinants of successful peroneal artery bypass

James A. DeWeese, MD Journal of Vascular Surgery

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Fate of the contralateral leg after infrainguinal bypass

Innominate artery trauma: A thirty-year experience

Benjamin B. Chang, MD, R. Clement Darling, MD, Devon E. M

Management of ischemic heel ulceration and gangrene: An evaluation of factors associated with successful healing Gerald S. Treiman, MDa, Gustavo S.C.

Proximal vein thrombosis secondary to hemodialysis catheterization complicated by arteriovenous fistula Joseph J. Piotrowski, M.D., Robert B. Rutherford,

Superficial femoral artery eversion endarterectomy: A useful adjunct for infrainguinal bypass in the presence of limited autogenous vein Spence M. Taylor,

Presentation transcript:

Axillofemoral bypass: Outcome and hemodynamic results in high-risk patients Joseph R. Schneider, MD, PhD, Martha D. McDaniel, MD, Daniel B. Walsh, MD, Robert M. Zwolak, MD, PhD, Jack L. Cronenwett, MD Journal of Vascular Surgery Volume 15, Issue 6, Pages 952-963 (June 1992) DOI: 10.1016/0741-5214(92)90451-D Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 1 Life-table patient survival after AxFB and AoFB. Number of patients entering next interval alive is indicated at each time point for both groups. Error bars indicate standard error of the mean (SEM). Survival line is broken when the SEM exceeds 10%. The difference is highly significant (log rank p < 0.001). Journal of Vascular Surgery 1992 15, 952-963DOI: (10.1016/0741-5214(92)90451-D) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 2 Life-table primary, (a) and secondary (b) patency after AxFB and AoFB. Number of patients entering the next interval alive with a patent graft is indicated at each time point for both groups. Error bars indicate standard error of the mean (SEM). Survival line is broken when the SEM exceeds 10%. AxFB is significantly inferior to AoFB in both primary, (p = 0.032) and secondary patency (p < 0.001). Journal of Vascular Surgery 1992 15, 952-963DOI: (10.1016/0741-5214(92)90451-D) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 3 Life-table primary patency after axillounifemoral and axillobifemoral bypass. Number of patients entering the next interval alive with a patent graft is indicated at each time point for both groups. Error bars indicate standard error of the mean (SEM). Survival line is broken when the SEM exceeds 10%. No significant difference exists between axillounifemoral and axillobifemoral primary patency (p = 0.484). Journal of Vascular Surgery 1992 15, 952-963DOI: (10.1016/0741-5214(92)90451-D) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 4 Linear regression analysis of postoperative ABI versus femoral outflow score; (a) for the side of an axillofemoral graft limb only, (b) for any revascularized leg after axillounifemoral or axillobifemoral bypass, (c) any revascularized leg after AoFB. Journal of Vascular Surgery 1992 15, 952-963DOI: (10.1016/0741-5214(92)90451-D) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions